Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesCost and Outcomes of Patients With Solitary Pulmonary Nodules Managed With Positron Emission Tomography
Chest, 10/07/09
Barnett PG et al. – Management of solitary pulmonary nodules is expensive, especially if the nodule is malignant or if the PET result is false positive. Among patients with malignant nodules, 2–year survival is poor. Compared to true positive PET results, false negative results are not associated with lower costs or better outcomes.
Today in Diagnostic/Lung Function...keeping you current
Receive free subspecialty "5-minute updates" via email
Pulmonary function testing in young children
Paediatric Respiratory Reviews, 11/04/09
Novel Influenza A(H1N1): Clinical Presentation, Diagnosis, and Management
Pediatric Emergency Care, 11/16/09
Newer diagnostic techniques for tuberculosis
Respiratory Medicine CME, 11/24/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09
New Advances in the Second-Line Treatment of Small Cell Lung Cancer
The Oncologist, 10/28/09
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Journal of Clinical Oncology, 11/05/09
Sponsor
Article Search
Sponsor